Author(s): Lebrecht D, Setzer B, Ketelsen UP, Haberstroh J, Walker UA
Background— Doxorubicin causes a chronic cardiomyopathy of unknown pathogenesis. We investigated whether acquired defects in mitochondrial DNA (mtDNA) and interconnected respiratory chain dysfunction may represent a molecular mechanism for its late onset.
Methods and Results— Rats were treated weekly with intravenous doxorubicin (1 mg/kg) for 7 weeks, starting at 11 weeks of age (group B). Controls received saline. Group C received doxorubicin identically to group B, but the course was started at 41 weeks of age. All rats were killed at week 48. Doxorubicin was also injected once, either 6 days (group D) or 2 hours (group E) before euthanasia. Heart and skeletal muscle were examined. Only group B rats developed a significant clinical, macroscopic, histological, and ultrastructural cardiomyopathy. Group B hearts had the lowest cytochrome c oxidase (COX) activity (24% of controls; P=0.003), the highest citrate synthase activity (135% of controls; P=0.005), and the highest production of superoxide. In group B, the respiratory subunit COXI, which is encoded by mtDNA, was reduced (P<0.001), as was mtDNA (49% of controls, P<0.001). Group C hearts differed from group B in their lower cardiomyopathy score (P=0.006), higher COX activity (P=0.02), and higher mtDNA content (P=0.04). Group B and to a lesser extent group C hearts contained deleted mtDNA. There was no detectable mitochondrial toxicity in group D and E hearts or in skeletal muscle.
Author(s): Long ZJ, Hu Y, Li XD, He Y, Xiao RZ, et al.
Author(s): Lipshultz SE, Sambatakos P, Maguire M, Karnik R, Ross SW, et al.
Author(s): Suzumiya J, Ohshima K, Tamura K, Karube K, Uike N, et al.
Author(s): Dalen VEC, Raphael MF, Caron HN, Kremer LC
Author(s): Swain SM, Whaley FS, Ewer MS
Author(s): Kobayashi S, Volden P, Timm D, Mao K, Xu X, et al.
Author(s): Krischer JP, Epstein S, Cuthbertson DD, Goorin AM, Epstein ML, et al.
Author(s): Lipshultz SE, Lipsitz SR, Mone SM, Goorin AM, Sallan SE, et al.
Author(s): Cario G, Rhein P, Mitlohner R, Zimmermann M, Bandapalli OR, et al.
Author(s): Aiken MJ, Suhag V, Garcia CA, Acio E, Moreau S, et al.
Author(s): Wouters KA, Kremer LC, Miller TL, Herman EH, Lipshultz SE
Author(s): Yeh ET, Bickford CL
Author(s): Vandecruys E, Mondelaers V, De Wolf D, Benoit Y, Suys B
Author(s): Barge-Caballero E, Segovia-Cubero J, Almenar-Bonet L, Gonzalez-Vilchez F, Villa-Arranz A, et al.
Author(s): Schweiger M, Dave H, Lemme F, Cavigelli-Brunner A, Romanchenko O, et al.
Author(s): Kurihara C, Nishimura T, Nawata K, Kinoshita O, Hisagi M, et al.
Author(s): Lipshultz SE, Franco VI, Cochran TR
Author(s): Orgel E, Zung L, Ji L, Finklestein J, Feusner J, et al.
Author(s): Lipshultz SE, Lipsitz SR, Sallan SE, Dalton VM, Mone SM, et al.
Author(s): Palazzuoli A, Gallotta M, Quatrini I, Nuti R
Author(s): Lipshultz SE, Miller TL, Scully RE, Lipsitz SR, Rifai N, et al.
Author(s): Armenian SH, Hudson MM, Mulder RL, Chen MH, Constine LS, et al.
Author(s): Harake D, Franco VI, Henkel JM, Miller TL, Lipshultz SE
Author(s): Lipshultz SE, Scully RE, Lipsitz SR, Sallan SE, Silverman LB, et al.
Author(s): Feuerstein GZ, Ruffolo RR
Author(s): Arozal W, Sari FR, Watanabe K, Arumugam S, Veeraveedu PT, et al.
Author(s): Goldberg JM, Scully RE, Sallan SE, Lipshultz SE
Author(s): Thompson PA, Rosner GL, Matthay KK, Moore TB, Bomgaars LR, et al.